• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIOMED GMBH & CO. MEDIZINTECHNIK KG COVERA VASCULAR COVERED STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIOMED GMBH & CO. MEDIZINTECHNIK KG COVERA VASCULAR COVERED STENT Back to Search Results
Catalog Number AVFM10080
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Restenosis (4576)
Date of Event 10/24/2023
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported through the results of the clinical trial that approximately three years and eleven days post angioplasty and stent placement procedure, the subject underwent av access circuit re-intervention on the target left arm cephalic vein stenosis.It was further reported that a standard percutaneous transluminal angioplasty was performed during re-intervention on the target lesion cephalic vein with initial stenosis of 70% and final residual stenosis of 0%.Reportedly, the re-intervention was successful and no new access was created.The current status of the patient was unknown.
 
Additional Manufacturer Narrative
H10: as the lot number for the device was provided, a review of the device history records will be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.H11: section a through f ¿ the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Additional Manufacturer Narrative
H11: manufacturing review: based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issue.However, the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.Investigation summary: the stent remains implanted.No x-ray images were provided for evaluation.There was no specific device deficiency reported and no indication for irregular stent placement.Pre and post dilation was performed.Based on the information available the investigation of a potential relation between stent placement and the restenosis of the target lesion is closed with inconclusive result.There was no reported specific deficiency of the placed stent; a root cause for the alleged restenosis could not be determined.Labeling review: relevant labeling applicable for this product was reviewed; it was found that the ifu sufficiently address the potential risk associated with the use of the covera vascular covered stent.Based on the ifu complications and adverse events may include the usual complications associated with endovascular stent and covered stent placement and dialysis shunt revisions, which includes obstruction of flow and restenosis of the target vessel.G3, h6 (method).Section a through f: the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported through the results of the clinical trial that approximately three years and eleven days post angioplasty and stent placement procedure, the subject underwent av access circuit re-intervention on the target left arm cephalic vein stenosis.It was further reported that a standard percutaneous transluminal angioplasty was performed during re-intervention on the target lesion cephalic vein with initial stenosis of 70% and final residual stenosis of 0%.Reportedly, the re-intervention was successful and no new access was created.The current status of the patient was unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COVERA VASCULAR COVERED STENT
Common Device Name
VASCULAR COVERED STENT
Manufacturer (Section D)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstr. 6
karlsruhe 76227
GM  76227
Manufacturer (Section G)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstr. 6
karlsruhe 76227
GM   76227
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key22000047
Report Number9681442-2025-00157
Device Sequence Number15270699
Product Code PFV
UDI-Device Identifier00801741106606
UDI-Public(01)00801741106606(17)220626(10)ANET3747
Combination Product (Y/N)N
Initial Reporter StateRI
Initial Reporter CountryUS
PMA/510(K) Number
P170042
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Reporter Type Manufacturer
Report Source Other,Study
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 07/16/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date06/26/2022
Device Catalogue NumberAVFM10080
Device Lot NumberANET3747
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/15/2025
Supplement Date Received by Manufacturer07/16/2025
Initial Report FDA Received Date05/12/2025
Supplement Report FDA Received Date08/01/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexMale
Patient Weight82 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-